clopidogrel nucleus
nucleus ehf. - clopidogrel - clopidogrel
clopidogrel esp pharma
esp pharma limited - clopidogrel - clopidogrel
clopidogrel caduceus pharma
caduceus pharma ltd. - clopidogrel - clopidogrel
clopidogrel tiefenbacher
alfred e. tiefenbacher gmbh & co. kg - clopidogrel - clopidogrel
clopidogrel tecnigen
tecnigen s.r.l. - clopidogrel - clopidogrel
clopidogrel actavis
bb farma s.r.l. - clopidogrel - clopidogrel
clopidogrel teva
bb farma s.r.l. - clopidogrel - clopidogrel
clopidogrel zentiva
bb farma s.r.l. - clopidogrel - clopidogrel
clopidogrel hec pharm
hec pharm gmbh - clopidogrel - clopidogrel
duoplavin
sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - agenti antitrombotici - duoplavin è indicato per la prevenzione secondaria di eventi aterotrombotici in pazienti adulti già in trattamento con clopidogrel e acido acetilsalicilico (asa). duoplavin is a fixed-dose combination medicinal product for continuation of therapy in:non st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention (pci);st segment elevation acute myocardial infarction (stemi) in patients undergoing a stent placement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. per ulteriori informazioni, si prega di fare riferimento alla sezione 5.